84 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
48
Ending by 2030
Dec 2030
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2030 · High confidence
Also notable
Ends Sep 2036 · High confidence
Also notable
Ends Nov 2038 · High confidence
Swallowable Drug Delivery Device and Method of Delivery
US 10,039,908
Cited by 144 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
Anti-Interleukin Antibody Preparations for Delivery into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device
US 11,548,940
Cited by 22 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2036.
Clotting Factor Preparations for Delivery into Tissue of the Intestinal Tract Using a Swallowable Drug Delivery Device
US 10,603,275
Cited by 30 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2038.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 23 to 28, 2026 · next Nov 23
- 5 fees due Dec 4 to 27, 2026 · next Dec 4
- 2 fees due Jan 2 to 16, 2027 · next Jan 2
- 1 fee due Feb 8, 2027The maintenance fee for Pharmaceutical Compositions and Methods for Fabrication of Solid Masses Comprising Polypeptides And/Or Proteins (US 11,718,665) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
- 2 fees due Apr 3 to 6, 2027 · next Apr 3
- 6 fees due May 7 to 28, 2027 · next May 7
- 4 fees due Jun 3 to 19, 2027 · next Jun 3
- 2 fees due Aug 4 to 16, 2027 · next Aug 4
- 5 fees due Sep 15 to 30, 2027 · next Sep 15
- 1 fee due Oct 28, 2027The maintenance fee for Device, System and Methods for the Oral Delivery of Therapeutic Compounds (US 10,632,251) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
- 1 fee due Nov 5, 2027The maintenance fee for Methods for Delivering Etanercept Preparations into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device (US 10,639,272) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
- 5 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,734,429 | Device, System and Methods for the Oral Delivery of Therapeutic Compounds In force · High confidence | In force | High confidence | |
| US 8,852,151 | Swallowable Drug Delivery Device and Method of Delivery In force · High confidence | In force | High confidence | |
| US 9,149,617 | Device, System and Methods for the Oral Delivery of Therapeutic Compounds In force · High confidence | In force | High confidence | |
| US 9,259,386 | A Therapeutic Preparation Comprising Somatostatin or Somatostatin Analogoue for Delivery into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · Medium confidence | In force | Medium confidence | |
| US 9,283,179 | GnRH PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE In force · Medium confidence | In force | Medium confidence | |
| US 9,284,367 | Therapeutic Agent Preparations for Delivery into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · High confidence | In force | High confidence | |
| US 9,402,807 | Therapeutic Agent Preparations for Delivery into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · Medium confidence | In force | Medium confidence | |
| US 9,415,004 | Therapeutic Agent Preparations for Delivery into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · Medium confidence | In force | Medium confidence | |
| US 9,457,065 | Methods for Delivering Insulin Preparations into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · High confidence | In force | High confidence | |
| US 9,486,414 | Method for Delivering Liraglutide Preparations into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 84: 22 patents ended · 17 applications pending · 17 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.